Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS's international advisory board holds first meeting
2009-11-28

Members of the International Advisory Board of the UFS in discussion with Prof. Dennis Francis (right), who is appointed as Dean of the Faculty of Education from the beginning of 2010. With him are Prof. Alice Pell from Cornell University in the USA and Dr Uri Ofir from Evalnet in Switzerland.
Photo:  Leatitia Pienaar


The International Advisory Board of the University of the Free State (UFS) had its first meeting on the Main Campus in Bloemfontein this week. It coincided with the launch of the six research clusters of the UFS.

Prof. Aldo Stroebel, Director: Internationalisation at the UFS, says internationalisation is a strategic priority to reach the University’s strategic goals. Internationalisation will bring a global awareness at all levels and will serve as a co-shaping factor and an instrument to produce well-rounded, internationally competent staff and students. It will also be an instrument to promote diversity, advance the UFS’s international standing and initiate and promote international collaborative research.

The advisory board will advise and guide the UFS leadership in the internationalisation process. He said the board would provide strategic guidance to the internationalisation efforts of the UFS and bring cutting-edge expertise to bear on the internationalisation policies, strategies and action plans of the institution.

Its members will help ensure that the University leadership is aware of relevant international trends and opportunities, and the board will use their experience to advise on appropriate actions. They will also act as advocates for the University in their own spheres of influence.

The board consists of Dr Jane Knight of the Ontario Institute for Studies in Education, University of Toronto, Canada; Prof. Alice Pell of the Cornell University, USA; Prof. Masafumi Nagao of the International Christian University, Japan; Dr Khotso Mokhele of Impala Platinum Holdings, South Africa; Prof. Joseph Stetar of the Seton Hall University, USA; and Dr Uri Ofir of Evalnet, Switzerland. Prof. Jonathan Jansen, Rector and Vice-Chancellor of the UFS, is the Chairperson of the board.

Prof. Stroebel says the UFS is honoured to have people of international standing and who are highly regarded in various fields on the board to guide the institution in its internationalisation endeavours.

Media release
Issued by: Lacea Loader
Deputy Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
27 November 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept